1. Introduction {#sec1}
===============

Nonceliac gluten sensitivity (NCGS) can be defined as a nonallergic condition in which the consumption of gluten can lead to symptoms similar to those observed in celiac disease (CD). NCGS is characterized by the absence of celiac specific antibodies (against tissue transglutaminase, endomysium, and/or deamidated gliadin peptide) and absence of classical enteropathy (Marsh 0-1) although an increased density of CD3+ intraepithelial lymphocytes can be observed in duodenal biopsies. Patients with NCGS may have variable HLA status, and positivity for HLA-DQ2 and/or DQ8 has been found in roughly 50% of patients with NCGS. Serological analyses of NCGS patients revealed a high prevalence (40--50%) of first generation antigliadin IgG antibodies. NCGS is characterized by symptoms that usually occur soon after gluten ingestion and disappear or improve with gluten withdrawal but relapse following gluten challenge. The clinical presentation of NCGS may be a combination of gastrointestinal symptoms, including abdominal pain, bloating, bowel habit abnormalities (diarrhoea or constipation), and systemic manifestations, that is "foggy mind," fatigue, muscle and joint pain, leg or arm numbness, eczema and skin rash, depression, and anemia. Similarly to patients with CD, subjects with clinical manifestations compatible with NCGS should start a gluten-free diet. Since it is still not clear whether NCGS is a permanent or transient condition, reintroduction of gluten after 1-2 years on a gluten-free diet can be considered \[[@B1], [@B2]\].

Rotavirus is a double-stranded RNA virus belonging to the family of *Reoviridae.*

The virus is transmitted by the faecal-oral route and infects intestinal cells causing gastroenteritis. Rotaviruses are the main cause of severe acute diarrhoea in children less than 5 years of age worldwide \[[@B3]\]. They are responsible for 453,000 deaths worldwide each year, which in most cases (85%) occur in developing countries \[[@B3]\]. The virus particle is composed of six viral proteins (VPs) called VP1, VP2, VP3, VP4, VP6, and VP7. Among these, the glycoprotein VP7 is located on the outer surface of the virus determining the specific G-type of the strain and plays a role in the development of immunity to infection \[[@B4]\].

We have previously described the presence, in active celiac disease (CD), of a subset of antitransglutaminase IgA antibodies that recognizes the viral protein VP-7 and is able to increase intestinal permeability and induce monocyte activation \[[@B5]\]. We then showed that the antirotavirus VP7 antibodies may be even detected before the CD onset and the detection of antitissue transglutaminase (tTG) and antiendomysium antibodies, showing a predictive role \[[@B6]\]. In addition, we observed that these antibodies were able to induce in human T84 intestinal cell line the modulation of genes involved in biological processes that represents typical features of CD \[[@B6]\]. Taken together, our data seem to provide a link between rotavirus infection and CD.

In this paper, we aim at clarifying some aspects of the pathogenesis of NCGS by a gene-array approach. In particular, we plan to verify the possibility of the involvement of an autoimmune mechanism in the disease. In addition, we also aim at investigating a possible involvement of rotavirus infection in the development of NCGS. For this purpose, we compared the global panel of modulated genes in NCGS to the dataset of human T84 intestinal cells treated with antirotavirus VP7 antibodies, described in our previous work \[[@B6]\], and to a dataset of acute phase of rotavirus infection, downloaded from the GEO (Gene Expression Omnibus) database, searching for transcriptional profiles that may be associated to viral infection.

2. Materials and Methods {#sec2}
========================

2.1. Patients {#sec2.1}
-------------

We studied a cohort of 16 patients (6 males and 10 females, mean age: 27.3 years) affected by NCGS, attending the Unit of Autoimmune Diseases and the Immunology Unit and Child Neuropsychiatry Unit at the University Hospital of Verona, Italy.

All the enrolled subjects were recruited after informed consent. Main symptoms were headache, dermatitis, chronic urticaria, muscle and joint pain, bloating, abdominal pain, diarrhoea, alternating bowel movements, and fatigue in a variable combination.

Diagnosis of NCGS was established when all the following criteria were met: (1) exclusion of wheat allergy by clinical history and determination of specific IgE; (2) exclusion of celiac disease by absence of celiac-specific antibodies tissue transglutaminase (tTG), endomysium (EMA), and/or deamidated gliadin peptides (DGP); (3) duodenal biopsy with a histological damage grade 0 to 1, according to Marsh\'s classification; (4) significant improvement of symptoms on strict gluten-free diet and relapse of symptoms after gluten reintroduction.

2.2. Detection of Anti-VP7 Peptide Antibodies {#sec2.2}
---------------------------------------------

The ELISA test for antibody binding to the synthetic peptides has been carried out as already described elsewhere with minor modifications \[[@B7]\]. The synthetic peptides were used at a concentration of 20 *μ*/mL in PBS to coat polystyrene plates (Immulon 2HB, Thermo). For the detection of antirotavirus VP7 peptide IgA antibodies, only the sera whose OD readings were higher than the mean plus three standard deviations of each serum dilution of the control group were considered positive. OD values higher than 0.140 were considered positive.

2.3. Gene Array {#sec2.3}
---------------

Peripheral blood cells were collected for analysis of gene expression profiles on a gluten-containing diet. PAXgene Blood RNA tubes (PreAnalytiX, Hombrechtikon, Switzerland) were used for blood collection and total RNA was extracted according to the protocol supplied by the manufacturer. Preparation of cRNA hybridization and scanning of arrays for each samples were performed following the manufacturer instructions (Affymetrix, Santa Clara, CA, USA) by Cogentech Affymetrix microarray unit (Campus IFOM IEO, Milan, Italy) using the Human Genome U133A 2.0 GeneChip (Affymetrix). The gene expression profiles were analysed using the GeneSpring software version 12.1 (Agilent Technologies, Santa Clara, CA, USA) that calculated a robust multiarray average of background-adjusted, normalized, and log-transformed intensity values applying the robust multiarray average algorithm (RMA). The normalized data were transformed to the log~2~ scale. The unpaired *t*-test was performed to determine which genes were modulated at a significant level (*p* ≤ 0.01), and *p* values were corrected for multiple testing by using Bonferroni correction. Finally, statistically significant genes were chosen for final consideration when their expression was at least 1.5-fold different in the test sample versus control sample. Genes that passed both the *p* value and the FC restriction were submitted to functional and pathway enrichment analysis according to the Gene Ontology (GO) annotations employing the Panther expression analysis tools (<http://pantherdb.org/>).

2.4. Protein-Protein Interaction (PPI) Network Construction and Network Modular Analysis {#sec2.4}
----------------------------------------------------------------------------------------

All the possible interactions among the protein products of DEGs were analysed with Search Tool for the Retrieval of Interacting Genes (STRING version 1.0; <http://string-db.org>/) a web-based database that includes experimental as well as predicted interaction information and covers more than 1100 sequenced organisms. Only protein-protein interaction (PPI) pairs that were confirmed by experimental studies were selected, and a score of ≥0.7 for each PPI pair was used to build a PPI network.

Cytoscape software \[[@B8]\] was used to define the topology of the built network, and the Molecular Complex Detection (MCODE) \[[@B9]\] was used to find densely connected region (modules) of the network that could be involved in the modulation of biological processes that are relevant for the disease pathogenesis. To find locally dense regions of a graph, MCODE applies a vertex-weighting scheme based on a clustering coefficient that is a measure of the degree to which nodes in a graph tend to cluster together.

The following settings in MCODE were used: degree cutoff = 2, K-core = 3, and max. depth = 100. Functional enrichment for a given module was assessed quantitatively using the Panther tool.

2.5. Analysis of the Association between DEGs and Human Diseases {#sec2.5}
----------------------------------------------------------------

We used the software Ingenuity Pathway Analysis (IPA, Ingenuity Systems) to evaluate diseases and disorders that could be statistically significantly associated to gene modulation observed in NCGS samples. The statistical significance of gene-disease associations was calculated in IPA by the Fisher\'s exact test (*p* ≤ 0.0001).

2.6. Detection of Soluble Mediators in GS Sera {#sec2.6}
----------------------------------------------

Serum levels of sCTLA-4, s PD-1, and sgp130/IL6ST were detected before and after gluten-free diet using commercially available ELISA kits according to the manufacturer\'s instructions. ELISA kits were purchased from Bender MedSystems (Milano, Italy) (sCTLA-4), from R&D Systems (Minneapolis, United States) (sgp130), and from EMELCA Bioscience (Clinge, Netherlands) (sPD-1).

2.7. FACS Analysis {#sec2.7}
------------------

Cells collected from patients and normal controls were cultured at a concentration of 1^∗^10^6^ cells/mL in 2 mL tubes containing 1 mL of RPMI 1640 + FCS 10% (Lonza, Basel, CH). Cells were stimulated overnight with Dynabeads Human T-Activator CD3/CD28 (Life Technologies, Carlsbad, CA, USA). The detection of IL-17 production was analysed using the IL-17 Secretion Assay (Miltenyi Biotec, Bergisch Gladbach, D) following the manufacturer\'s instruction. Briefly, cells were washed with 2 mL of cold buffer at 300 ×g for 5 minutes at 4°C, and the pellet was resuspended in 90 *μ*L of cold medium. Cells were then incubated with 10 *μ*L of IL-17 Catch Reagent for 5 minutes in ice and cultured in 1 mL of warm medium at 37°C for 45 minutes under slow continuous rotation. Cells were then washed with cold buffer and resuspended in 75 *μ*L of cold buffer; 10 *μ*L of IL-17 Detection Antibody APC, 10 *μ*L of anti-CD3 PerCP (Becton Dickinson, Franklin Lakes, NJ, USA), and 5 *μ*L of anti-CD4 APC-H7 (Becton Dickinson) monoclonal antibodies were added. Incubation was carried out in ice for 10 minutes. Finally, cells were washed and resuspended in an appropriate volume of PBS and acquired on a FACSCanto II cytometer (Becton Dickinson). Analysis was performed with FlowJo 9.3.3 software (Tree Star, Ashland, OR, USA).

2.8. Statistical Analysis {#sec2.8}
-------------------------

Data obtained from the analysis of the soluble mediators CTLA-4, gp130, and PD-1 and from the detection of antigliadin antibodies were submitted to statistical testing using the Wilcoxon nonparametric statistical hypothesis test for paired samples.

Data obtained from the ELISA test for the detection of antirotavirus VP7 peptide antibodies were submitted to statistical testing using the Mann--Whitney nonparametric test. Statistical analysis was performed using GraphPad Prism Software version 5.00 (GraphPad Software, La Jolla, California, USA, [http://www.graphpad.com](http://www.graphpad.com/)).

3. Results and Discussion {#sec3}
=========================

Many aspects of NCGS are still unknown; in particular, it is still not clear whether the disease is permanent or transient or whether the disease has features of autoimmunity. The pathogenesis of NCGS is also unclear and data obtained so far suggest a prevalent activation of innate immune responses \[[@B2]\].

We aimed at clarifying some aspects of NCGS pathogenesis using a gene array approach which we successfully used in the study of many immune-mediated diseases \[[@B6], [@B10]--[@B12]\].

<https://www.ncbi.nlm.nih.gov/pubmed/16318412>In order to identify specific gene signatures typically associated with NCGS, we compared the gene expression profiles of 8 PBC samples obtained from individual NCGS patients with 10 PBC samples obtained from healthy age- and sex-matched donors. We observed that the disease has a profound impact on gene expression profiles since a large number of differentially expressed genes (DEGs) (1293, represented by 1521 modulated probe sets) complied with the Bonferroni-corrected *p* value criterion (*p* ≤ 0.01) and the fold change criterion (FC ≥ 1.5) showing robust and statistically significant variation between healthy controls and NCGS samples. In particular, 695 and 598 genes resulted to be up- and downregulated, respectively (Additional [Table 1](#supplementary-material-1){ref-type="supplementary-material"}).

DEGs were submitted to functional enrichment analysis according to terms of the Gene Ontology (GO) biological processes (BP) and canonical pathways. The most enriched biological process was "immune system" followed by "intracellular signal transduction" ([Table 1](#tab1){ref-type="table"}). In addition, several enriched terms were related to the immune response gene category, including "leukocyte differentiation," "leukocyte activation involved in immune response," "T cell differentiation," "neutrophil degranulation," "adaptive immune response," and "defense response." Interestingly, we observed an enrichment in "cellular response to organic substance," "cellular response to endogenous stimulus," and "viral process." The BP named "viral process" is defined by the Gene Ontology Consortium as a "multi-organism process in which a virus is a participant and the other participant is the host." This term is related to the infection of a host cell, the replication of the viral genome, the viral transcription, and the assembly of progeny virus particles.

Pathway enrichment analysis showed that the most enriched signaling pathways were "inflammation mediated by chemokine and cytokine," "apoptosis," and "angiogenesis," followed by "T cell activation" and "B cell activation" ([Table 1](#tab1){ref-type="table"}). Other enriched pathways were: "integrin signaling," "EGF receptor signaling," "Toll-like receptor signaling," "PI3 kinase," "interleukin signaling," and JAK/STAT signaling. Since the majority of the top-enriched functional classes and pathways were related to the immune system, we selected, within the entire data set, all modulated genes associated to the "Immune response" GO term to better characterize the immunological processes that are involved in NCGS pathogenesis. Although both innate and adaptive immunity play a crucial role in the development of CD, NCGS has been mainly associated with activation of the innate immune response \[[@B2]\].

It is therefore surprising to notice that both transcripts involved in the innate immune response as well as genes of the adaptive immune response were well represented in our dataset ([Table 2](#tab2){ref-type="table"}).

In this regard, 14 genes involved in NK activity were modulated in NCGS samples (i.e., LILRA1, LILRA2, CLEC2D, and KLRC4). Moreover, several genes involved in macrophage activation were modulated in NCGS including TNFRSF10B, the ligand of the death receptors TRAIL that play important roles in set up both innate and adaptive immune responses against pathogens \[[@B13]\], and the scavenger receptors MRC1/CD206 \[[@B14]\] and MARCO, a member of the class A scavenger receptor family strongly upregulated in M*Φ* by various microbial stimuli in a TLR-dependent manner \[[@B15]\].

Noteworthy, 38 genes prevalently related to B cell activity (i.e., IL2RG, IL6R, KLF12, and CD27) were also modulated, indicating an important role for this cell subset in NCGS, 20 genes involved in T cell activation were upregulated in NCGS samples (i.e., CD28, CD3E, CD3G, and CTLA-4). Remarkably, Th17-lymphocyte-related genes and transcripts that can modulate Th17 cell development and functions were overexpressed including IL4R, IL2RG, IL6ST, IL1B, IL7R, STAT6, STAT5B, SOCS3, and CXCL2.

DEGs indicate therefore active involvement of both arms of the adaptive immune response (i.e., T and B cells response) and a prevalent upregulation of several Th17-related genes in the T cell response category. It is well known that Th17 cells play an important role in autoimmunity and have been implicated in the pathogenesis of psoriasis and in the amplification of inflammation in rheumatoid synovitis and in lupus nephritis \[[@B16]--[@B18]\].

In the NCGS dataset, 6 type I interferon inducible genes (IFIG) were upregulated (IFNA17, IRF5, IRF3, STAT2, STAT1, and LY9), thus indicating the presence of an IFN type I signature, typically associated with autoimmune disease such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Crohn\'s disease, and Sjogren syndrome \[[@B19]--[@B25]\].

In this respect, it is well known that Th17 cells and related cytokines are crucial in promoting autoimmunity, in particular, when they act in synergy with type I IFN-driven inflammation. In the presence of IFN type I signature, CCR6^+^ memory T-helper cells producing IL-17A, IL-17F, IL-21, and/or IL-22 are increased in SLE, \[[@B26]\] indicating that, in the pathogenesis of systemic autoimmune diseases, IFN type I signature coacts with Th17 cells and related cytokines.

In order to further confirm our gene expression data on overexpression of IFIG and Th17 pathways, we analysed the presence of IL-17-producing CD4+ T cells and found a significantly (*p* = 0.0159) increased percentage of these cells in PBMC of patients with NCGS compared with normal subjects ([Figure 1](#fig1){ref-type="fig"}).

The analysis of genes modulated in gluten sensitivity was paralleled by the detection of some of the corresponding soluble mediators in the sera of NCGS patients. We analysed selected molecules that are widely recognized to be associated to an autoimmune response, including sCTLA-4, sPD-1, and sgp130/IL6ST. [Figure 2](#fig2){ref-type="fig"} shows the concentration of these molecules in the sera of NCGS patients before and after gluten-free diet. The serum levels of all the molecules tested were significantly higher in NCGS before GFD than after GFD.

In order to gain further insights into the molecular mechanisms relevant in NCGS pathogenesis, we constructed a protein-protein interaction (PPI) network starting from all the 1293 DEGs. The resulted PPI network contained 853 nodes and 3512 edges ([Figure 3](#fig3){ref-type="fig"}). By performing a modular analysis of the constructed PPI network, we were able to identify clusters of the most densely interconnected nodes (modules) and to extrapolate 15 main modules of genes displaying the highest degree of connection. [Figure 4](#fig4){ref-type="fig"} shows a graphical representation of such modules, where the nodes represent proteins and the edges indicate their relations.

All modules were submitted to enrichment analysis to find enriched GO biological processes and pathways.

Among the 15 modules in particular, five (module 1, 3, 7, 10, and 14) showed a prevalent enrichment in BP and pathways associated to the activation of T cells. Similarly, "B cell activation" pathways were significantly enriched in modules 1, 9, 10, and 14. Interestingly, in modules 3, 10, and 11, we observed an enrichment in the JAK--STAT signaling pathway, which is highly relevant to human autoimmunity \[[@B27]\] and plays a role in the intestinal mucosal immune homeostasis as well as in intestinal epithelial repair and regeneration \[[@B28]\]. We also observed that module 11 contained several genes involved in Th-17 cell functions (i.e., IL2RG, IL4R, IL6ST, IL7R, SOCS3, STAT5B, and STAT6) and several IFIG, including IFNA17, STAT1, and STAT2. Other IFIG genes were ascribed to module 9 which also shows an enrichment in BPs associated to type I interferon signaling, including positive regulation of type I interferon production, positive regulation of interferon-beta production, and type I interferon biosynthetic process ([Table 3](#tab3){ref-type="table"}).

Loss of the intestinal barrier integrity is a typical feature of CD and represents an important mechanism of autoimmunization through the passage of antigens across the intestinal epithelium \[[@B29]\]. However, Sapone et al. \[[@B29]\] have shown that NCGS patients have normal intestinal permeability when compared to CD patients, as assessed by the lactulose-mannitol test.

Indeed, in module 13, in which the most enriched BP was "adherent junction assembly," we observed a reduced expression of molecules involved in cell adhesion including CDH1 (epithelial cadherin), CTNNA1, VCL, and CTTN, a molecule expressed on the apical surface of the polarized epithelium. In the same module, we also observed underexpression of Rac1, a critical regulator of intestinal epithelial barrier functions \[[@B30]\] and EGF, known to protect intestinal barrier integrity by stabilizing the microtubule cytoskeleton \[[@B31]\] and upregulation of FYN and PIK3R1, both involved in the signaling pathway by which IFN*γ* increases intestinal permeability \[[@B32]\].

The gene expression data would therefore indicate deregulation of adherent junctions and altered intestinal permeability also in NCGS, which seems to be in contrast with the data of Sapone et al. Nevertheless, it is important to point out that the lactulose-mannitol test may not be sensitive enough to detect mild alterations of the intestinal barrier function in patients with NCGS.

In module 12, the most enriched pathway was "inflammation mediated by chemokine and cytokine signaling"; this pathway was also enriched in modules 9, 10, and 11, which is consistent with inflammatory/autoimmune origin of NCGS.

Moreover, modules 1, 2, 7, and 10 were enriched in BPs related to viral infection including "viral process," "viral gene expression," "intracellular transport of virus," and "regulation of defense response to virus."

In addition, we observed that modules 10 and 11 showed enrichments in the gamma interferon pathways typically associated to the innate response to viruses \[[@B33]\].

Therefore, to further clarify the relationship between viral infections and NCGS, we searched in the IPA software database to find all diseases that are most likely to be statistically significantly associated to the genes modulated in the NCGS dataset. We found that, in the resulting list of most significantly associated diseases, "Infectious diseases" ranked first and, among these, "Viral infection" showed the best statistical *p* value ([Figure 5(a)](#fig5){ref-type="fig"}). Moreover, we could find a cluster of 134 DEGs that, in our NCGS dataset, showed a modulation that was consistent with a process of viral infection ([Figure 5(b)](#fig5){ref-type="fig"}). Based on these data, we aimed at investigating whether rotavirus, known to be linked to CD, \[[@B5], [@B6], [@B34]\] could also play a role in NCGS.

In the second part of our study, we made a comparison between the dataset obtained from our previous analysis of intestinal human T84 cells treated with anti-VP7 antibodies (that we indicate in this paper as "T84 dataset") and genes modulated in NCGS. We found that 529 genes modulated in NCGS (accounting for the 41% of genes modulated in this dataset) were also modulated in treated T84 cells. Interestingly, several DEGs that were shared by the two datasets are involved in BP that may be related to the pathogenesis of celiac disease, including apoptosis, inflammatory and immune response, cell proliferation, cell differentiation, cell junctions, matrix metalloproteases, receptors and signal transducers, cytoskeleton components, ion transport and exchange, and EGF receptor pathway. [Table 4](#tab4){ref-type="table"} shows a selection of genes ascribed to the abovementioned functional classes. As a whole in NCGS dataset, the modulation of genes ascribed to the abovementioned categories indicated an upregulation of apoptotic genes accompanied by a downregulation of genes involved in cell differentiation and an increased transcription of proliferative genes. All these observation are in agreement with what we described on human T84 cells treated with antirotavirus Vp7 peptide antibodies and are related to the typical features of celiac disease. Indeed in CD, an increased apoptosis is the main cause of villous atrophy that is also sustained by a dysregulation of cell differentiation \[[@B35]\]. Moreover, it has been observed that the increase of intestinal cell proliferation leads to crypt hyperplasia seen in celiac disease \[[@B35]\]. Other aspects of CD previously observed in our T84 treated cells, that are paralleled by the gene modulated observed in NCGS, are the upregulation of members of the epidermal growth factor receptor (EGFR) signaling pathway and the concomitant downregulation of cell adhesion molecules beside a deregulation of ion transport. Noteworthy, the activation of EGFR signaling has been already observed in CD \[[@B36]\], and dysfunction of cell adhesion and transport are typical features of epithelial cells from active CD \[[@B37]\].

In this regard, it is worthwhile mentioning that patients with NCGS have normal to mildly inflamed mucosa (Marsh 0-1), while partial or subtotal villous atrophy and crypt hyperplasia are hallmarks of CD. Nevertheless, we cannot exclude that some NCGS patients, especially those positive for HLA-DQ2 and/or DQ8, may switch to classical CD in the course of the follow-up.

Since a large part of DEGs in the NCGS paralleled the modulation of genes seen in human T84 cells treated with antirotavirus Vp7 peptide antibodies, we next aimed at identifying the presence of such antibodies in sera of NCGS patients. We therefore tested in ELISA assay the sera from 16 NCGS patients and 20 healthy subjects for the detection of antirotavirus VP7 peptide antibodies. We found that these antibodies were present in 6 out of 16 (37%) NCGS patients while were not detected in the sera of healthy subjects. [Figure 5(c)](#fig5){ref-type="fig"} shows that the levels of such antibodies are significantly different in the two set of tested samples (*p* \< 0.0001). The detection of these antibodies in NCGS patients may be relevant to the pathogenesis of the NCGS given their ability to modulate sets of genes in intestinal epithelial cells as we previously demonstrated \[[@B6]\].

Taken together, the modulation of highly connected genes associated to the viral infection process and the presence of anti-VP7 antibodies in the sera of some NCGS patients may suggest that a link also exists between immune response to rotavirus infection and NCGS.

In this perspective, since anti-VP7 rotavirus antibodies are often present before the onset of CD, preceding the detection of celiac specific autoantibodies, \[[@B6]\] it is tempting to speculate that NCGS patients with CD genetic predisposition (DQ2/DQ8) and presence of anti-VP7 antibodies may develop CD in the course of the follow-up.

Therefore, to further clarify the relationship between rotavirus infection and NCGS, we decided to perform an integrative bioinformatics analysis using the dataset GSE50628 downloaded from GEO (Gene Expression Omnibus) database ([http://www.ncbi.nlm.nih.gov/geo/](http://www.ncbi.nlm.nih.gov/geo)) that included samples of peripheral blood cells from patients affected by acute rotavirus infection (named in the paper "Rotavirus infection dataset"). This dataset was analysed to detect significantly modulated genes (Additional [Table 2](#supplementary-material-1){ref-type="supplementary-material"}), and a comprehensive GO analysis was carried out on all datasets including NCGS, Rotavirus infection, and T84 datasets that we analysed in our previous work \[[@B6]\].

We then searched on the four datasets for the presence of genes associated to GO terms containing the words "virus" and/or "viral" and we found in all datasets a great number of such terms to which modulated genes were connected/related.

The searched terms explored a wide range of biological processes associated to viral infection from the entry of virus in the host cell, viral transcription and gene expression, modulation of host physiology by virus to cellular response to virus.

All the GO terms retrieved in the three datasets are listed in Additional [Table 3](#supplementary-material-1){ref-type="supplementary-material"}.

[Table 5](#tab5){ref-type="table"} shows selected genes modulated in the three datasets that are ascribed to the most representative GO terms, including viral transcription, viral gene expression, response to virus, viral genome replication, and viral life cycle.

Moreover, the GO analysis of the abovementioned datasets was complemented by searching for transcripts involved in immune response.

In the "T84 dataset," we found upregulation for the T cell costimulatory molecule ICOSLG, the transcriptional regulator that is crucial for the development and inhibitory function of regulatory T cells, \[[@B38]\] interleukin-6 that is pivotal for the development of Th-17 cells \[[@B39]\], and FCGR2B that is involved in the phagocytosis of immune complexes and in modulation of antibody production by B cells \[[@B40]\] ([Table 6](#tab6){ref-type="table"}).

In the "Rotavirus infection" dataset, we found upregulation for molecules that are crucial in the immune response including the BLK gene, involved in transmitting signals through surface immunoglobulins, supporting the pro-B to pre-B transition, \[[@B41]\] MR1/MAIT playing a role in the development of the mucosal-associated invariant T cells (MAIT), \[[@B42]\] TNFRSF4 involved in T cell proliferation \[[@B43]\], and HCST/DAP10 playing a role in triggering cytotoxicity against both stressed and infected by virus target cells \[[@B44]\] ([Table 7](#tab7){ref-type="table"}).

Interestingly, in all the datasets, we found the presence of modulated genes involved in the type I interferon signaling, that is central in autoimmunity, and in molecular pathways involved in the immune response to viral infection, including the Toll-like receptors, and the type I and gamma interferon pathways (see Tables [2](#tab2){ref-type="table"}, [6](#tab6){ref-type="table"}, and [7](#tab7){ref-type="table"}).

Taken together, our data seem to indicate that NCGS has features of autoimmunity and that an immune response to rotavirus may play a role in some cases of NCGS.

4. Conclusions {#sec4}
==============

NCGS is an emerging new clinical entity lacking specific diagnostic biomarkers which has been reported to occur in 6--10% of the population. Interestingly, up to 50% of these patients carry HLA-DQ2 and/or HLA-DQ8 genes. NCGS patients may complain gastrointestinal (e.g., diarrhoea/constipation, abdominal pain, bloating) and/or extraintestinal symptoms ("foggy mind," headache, dermatitis, etc.) which recede with GFD. The pathogenesis of NCGS is still unclear and the data, so far obtained, suggest a predominant activation of the innate immune responses.

Our data indicate a concomitant involvement of the adaptive immune system and suggest that NCGS may have an autoimmune origin. This is based both on gene expression data (i.e., TH17-IFNA I signatures) and on the presence of TH17 cells and of serological markers of autoimmunity in NCGS. Our results also indicate a possible involvement of rotavirus infection in the pathogenesis of NCGS, similarly to what we have previously shown in CD.
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![Flow cytometric analysis of CD4+T cells releasing IL-17 in patients with NCGS. Panel displays the mean percentage of CD4+T cells releasing IL-17 of 10 healthy donors and 8 NCGS patients. PBMCs were stimulated overnight with anti-CD3/-CD28-coated beads. *p* value calculated with the Mann--Whitney nonparametric statistical test was 0.0159.](JIR2018-9419204.001){#fig1}

![Serum levels of selected soluble mediators in NCGS patients and in normal subject sera. The histograms represent the mean of the results obtained in 20 healthy donors and in 16 NCGS patients. *p* values calculated with the Wilcoxon nonparametric statistical test for paired samples were: *p* \< 0.0001 for sCTLA-4, *p* \< 0.001 for sPD-1, and *p* \< 0.05 for sgp130.](JIR2018-9419204.002){#fig2}

![Protein-protein interaction (PPI) network of DEGs in NCGS patients.](JIR2018-9419204.003){#fig3}

![Modules originated from the network analysis of DEGs in NCGS patients.](JIR2018-9419204.004){#fig4}

![(a) List of diseases which are most likely to be statistically significantly associated and compatible with the transcriptional profile observed in NCGS. (b) DEGs in NCGS showing a modulation consistent with a viral infection process. (c) Detection of antibodies directed against the rotavirus VP7 peptide in the sera of patients with NCGS. Each circle represents a measurement for one patient, and the dashed horizontal line indicates the threshold for positivity (O.D. 0.140). The statistical *p* value was calculated with the Mann--Whitney test (*p* \< 0.0001).](JIR2018-9419204.005){#fig5}

###### 

Biological processes and pathways that were enriched in the NCGS dataset.

  ------------------------------------------------------------------- ---------------
  *Biological processes*                                              *p value* ^∗^
  Immune system process                                               6.3 × 10^−26^
  Intracellular signal transduction                                   4.6 × 10^−16^
  Cellular response to organic substance                              1.5 × 10^−13^
  Cell surface receptor signaling pathway                             8.2 × 10^−10^
  Leukocyte differentiation                                           6.3 × 10^−9^
  Viral process                                                       7.7 × 10^−9^
  Leukocyte activation involved in immune response                    8.0 × 10^−8^
  Apoptotic process                                                   2.2 × 10^−6^
  Cellular response to endogenous stimulus                            3.0 × 10^−6^
  T cell differentiation                                              5.6 × 10^−5^
  Neutrophil degranulation                                            5.6 × 10^−5^
  Adaptive immune response                                            6.5 × 10^−5^
  Defense response                                                    6.8 × 10^−5^
  *Pathways*                                                          *p value* ^∗^
  Inflammation mediated by chemokine and cytokine signaling pathway   2.1 × 10^−7^
  Apoptosis signaling pathway                                         1.6 × 10^−4^
  Angiogenesis                                                        4.1 × 10^−4^
  T cell activation                                                   5.3 × 10^−4^
  B cell activation                                                   5.7 × 10^−4^
  Integrin signaling pathway                                          7.8 × 10^−4^
  EGF receptor signaling pathway                                      4.0 × 10^−3^
  Toll like receptor signaling pathway                                4.6 × 10^−3^
  PI3 kinase pathway                                                  7.6 × 10^−3^
  Interleukin signaling pathway                                       8.1 × 10^−3^
  JAK/STAT signaling pathway                                          1.6 × 10^−2^
  ------------------------------------------------------------------- ---------------

^∗^Bonferroni corrected.

###### 

Genes modulated in NCGS patients that are involved in immune response and molecular signalings.

  Probe set ID                            *p* value   Gene symbol   Gene title                                                             FC      Representative public ID
  --------------------------------------- ----------- ------------- ---------------------------------------------------------------------- ------- --------------------------
  *T cell activation*                                                                                                                              
  203809_s\_at                            \<0.001     AKT2          v-akt murine thymoma viral oncogene homolog 2                          2.36    NM_001626
  211861_x\_at                            \<0.001     CD28          CD28 molecule                                                          2.75    AF222343
  205456_at                               \<0.001     CD3E          CD3e molecule, epsilon (CD3-TCR complex)                               2.67    NM_000733
  206804_at                               \<0.001     CD3G          CD3g molecule, gamma (CD3-TCR complex)                                 2.13    NM_000073
  211027_s\_at                            \<0.001     IKBKB         Inhibitor of kappa light polyp. gene enhancer in B cells, kinase *β*   2.69    NM_001190720
  213281_at                               0.007       JUN           jun proto-oncogene                                                     3.07    NM_002228.3
  204890_s\_at                            \<0.001     LCK           Lymphocyte-specific protein tyrosine kinase                            2.05    U07236
  213490_s\_at                            \<0.001     MAP2K2        Mitogen-activated protein kinase kinase 2                              1.83    NM_030662
  214786_at                               0.013       MAP3K1        Mitogen-activated protein kinase kinase kinase 1                       1.52    NM_005921
  210671_x\_at                            \<0.001     MAPK8         Mitogen-activated protein kinase 8                                     2.33    NM_001278548
  211230_s\_at                            \<0.001     PIK3CD        Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic sub. Δ       1.88    U57843
  212249_at                               0.002       PIK3R1        Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)                2.76    NM_181523
  216551_x\_at                            0.001       PLCG1         Phospholipase C, gamma 1                                               1.53    NM_002660
  208640_at                               \<0.001     RAC1          Rho family, small GTP-binding protein Rac1                             −1.92   NM_006908
  207419_s\_at                            \<0.001     RAC2          Rho family, small GTP-binding protein Rac2                             2.31    NM_002872
  217576_x\_at                            0.002       SOS2          Son of sevenless homolog 2                                             1.90    NM_006939
  216042_at                               \<0.001     TNFRSF25      Tumor necrosis factor receptor superfamily, member 25                  2.40    NM_148965
  221331_x\_at                            \<0.001     CTLA4         Cytotoxic T-lymphocyte-associated protein 4                            2.26    NM_005214
  206569_at                               \<0.001     IL24          Interleukin 24                                                         2.84    NM_006850
  203828_s\_at                            0.003       IL32          Interleukin 32                                                         2.10    NM_004221
  *B cell mediated immune response*                                                                                                                
  211027_s\_at                            \<0.001     IKBKB         Inhibitor of kappa light polyp. gene enhancer in B cells, kinase *β*   2.69    NM_001190720
  213281_at                               0.007       JUN           jun proto-oncogene                                                     3.07    NM_002228.3
  202626_s\_at                            0.004       LYN           v-yes-1 Yamaguchi sarcoma viral related oncogene homolog               −2.22   AI356412
  213490_s\_at                            \<0.001     MAP2K2        Mitogen-activated protein kinase kinase 2                              1.83    NM_030662
  210671_x\_at                            \<0.001     MAPK8         Mitogen-activated protein kinase 8                                     2.33    NM_001278548
  211230_s\_at                            \<0.001     PIK3CD        Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic sub. Δ       1.88    U57843
  32540_at                                \<0.001     PPP3CC        Protein phosphatase 3, catalytic subunit, gamma isozyme                2.00    NM_001243975
  208640_at                               \<0.001     RAC1          Rho family, small GTP-binding protein Rac1                             −1.92   NM_006908
  207419_s\_at                            \<0.001     RAC2          Family, small GTP-binding protein Rac2                                 2.31    NM_002872
  217576_x\_at                            0.002       SOS2          Son of sevenless homolog 2                                             1.90    NM_006939
  207540_s\_at                            0.008       SYK           Spleen tyrosine kinase                                                 −1.92   NM_003177
  207224_s\_at                            0.003       SIGLEC7       Sialic acid-binding Ig-like lectin 7                                   −2.21   NM_016543
  206150_at                               0.004       CD27          CD27 molecule                                                          1.96    NM_001242
  214447_at                               0.005       ETS1          v-ets erythroblastosis virus E26 oncogene homolog 1                    2.25    NM_005238
  201328_at                               0.012       ETS2          v-ets erythroblastosis virus E26 oncogene homolog 2                    −1.83   NM_005239
  212420_at                               0.001       ELF1          E74-like factor 1 (ets domain transcription factor)                    1.94    KJ896761
  211825_s\_at                            \<0.001     FLI1          Friend leukemia virus integration 1                                    2.28    AF327066
  215967_s\_at                            \<0.001     LY9           Lymphocyte antigen 9                                                   2.08    NM_002348
  210690_at                               0.001       KLRC4         Killer cell lectin-like receptor subfamily C, member 4                 2.23    U96845
  204116_at                               \<0.001     IL2RG         Interleukin 2 receptor, gamma                                          1.84    NM_000206
  217489_s\_at                            \<0.001     IL6R          Interleukin 6 receptor                                                 1.79    S72848
  204863_s\_at                            \<0.001     IL6ST         Interleukin 6 signal transducer (gp130, oncostatin M receptor)         4.52    NM_002184
  206966_s\_at                            \<0.001     KLF12         Kruppel-like factor 12                                                 1.83    AH010423
  219878_s\_at                            \<0.001     KLF13         Kruppel-like factor 13                                                 1.89    NM_015995
  219386_s\_at                            \<0.001     SLAMF8        SLAM family member 8                                                   −2.27   NM_020125
  210405_x\_at                            0.003       TNFRSF10B     Tumor necrosis factor receptor superfamily, member 10b                 1.50    NM_003842
  219386_s\_at                            \<0.001     SLAMF8        SLAM family member 8                                                   −2.27   NM_020125
  210405_x\_at                            0.003       TNFRSF10B     Tumor necrosis factor receptor superfamily, member 10b                 1.50    NM_003842
  203508_at                               0.005       TNFRSF1B      Tumor necrosis factor receptor superfamily, member 1B                  −2.06   NM_001066
  216042_at                               \<0.001     TNFRSF25      Tumor necrosis factor receptor superfamily, member 25                  2.40    NM_148965
  218856_at                               0.008       TNFRSF21      Tumor necrosis factor receptor superfamily, member 21                  −1.68   NM_014452
  206181_at                               0.003       SLAMF1        Signaling lymphocytic activation molecule family member 1              1.65    NM_003037
  210796_x\_at                            \<0.001     SIGLEC6       Sialic acid-binding Ig-like lectin 6                                   1.58    D86359
  211192_s\_at                            \<0.001     CD84          CD84 molecule                                                          2.55    AF054818
  220132_s\_at                            \<0.001     CLEC2D        C-type lectin domain family 2, member D                                3.18    NM_013269
  204773_at                               0.005       IL11RA        Interleukin 11 receptor, alpha                                         1.56    AY532110
  210850_s\_at                            \<0.001     ELK1          ELK1, member of ETS oncogene family                                    1.60    AF000672
  209894_at                               0.002       LEPR          Leptin receptor                                                        −2.10   U50748
  203005_at                               0.006       LTBR          Lymphotoxin beta receptor (TNFR superfamily, member 3)                 −1.92   NM_002342
  *NK cell activation*                                                                                                                             
  220132_s\_at                            \<0.001     CLEC2D        C-type lectin domain family 2, member D                                3.18    NM_013269
  203233_at                               0.014       IL4R          Interleukin 4 receptor                                                 1.50    NM_000418
  210152_at                               0.007       LILRB4        Leukocyte immunoglobulin-like receptor, subfamily B, member 4          −1.83   NM_001278426
  210784_x\_at                            0.012       LILRA6        Leukocyte immunoglobulin-like receptor, subfamily A, member 6          −1.74   NM_024318
  211405_x\_at                            0.003       IFNA17        Interferon, alpha 17                                                   1.59    NM_021268
  210660_at                               0.008       LILRA1        Leukocyte immunoglobulin-like receptor, subfamily A, member 1          −2.81   NM_001278319
  207857_at                               0.016       LILRA2        Leukocyte immunoglobulin-like receptor, subfamily A, member 2          −2.35   NM_006866
  210690_at                               0.001       KLRC4         Killer cell lectin-like receptor subfamily C, member 4                 2.23    U96845
  206881_s\_at                            0.013       LILRA3        Leukocyte immunoglobulin-like receptor, subfamily A, member 3          −2.96   NM_006865
  210313_at                               0.003       LILRA4        Leukocyte immunoglobulin-like receptor, subfamily A, member 4          −1.83   NM_012276
  215838_at                               0.012       LILRA5        Leukocyte immunoglobulin-like receptor, subfamily A, member 5          −3.15   NM_181985
  210146_x\_at                            0.004       LILRB2        Leukocyte immunoglobulin-like receptor, subfamily B, member 2          −3.41   AF004231
  208982_at                               0.008       PECAM1        Platelet/endothelial cell adhesion molecule 1                          −1.73   M37780
  203828_s\_at                            0.003       IL32          Interleukin 32                                                         2.10    NM_004221
  *Macrophage activation*                                                                                                                          
  210405_x\_at                            0.003       TNFRSF10B     Tumor necrosis factor receptor superfamily, member 10b                 1.50    NM_003842
  221900_at                               0.003       COL8A2        Collagen, type VIII, alpha 2                                           −1.62   NM_005202
  205819_at                               \<0.001     MARCO         Macrophage receptor with collagenous structure                         −3.01   NM_006770
  208602_x\_at                            \<0.001     CD6           CD6 molecule                                                           3.67    NM_006725
  207540_s\_at                            0.008       SYK           Spleen tyrosine kinase                                                 −1.92   NM_003177
  203508_at                               0.005       TNFRSF1B      Tumor necrosis factor receptor superfamily, member 1B                  −2.06   NM_001066
  204438_at                               0.012       MRC1          Mannose receptor, C type 1                                             −2.04   NM_002438
  202269_x\_at                            0.006       GBP1          Guanylate binding protein 1, interferon-inducible                      −1.77   NM_002053
  208982_at                               0.008       PECAM1        Platelet/endothelial cell adhesion molecule 1                          −1.73   M37780
  *Complement activation*                                                                                                                          
  205500_at                               0.006       C5            Complement component 5                                                 −1.60   NM_001735
  206244_at                               0.003       CR1           Complement component (3b/4b) receptor 1 (Knops blood group)            −1.79   NM_000573
  *Response to gamma interferon*                                                                                                                   
  205831_at                               0.001       CD2           CD2 molecule                                                           2.00    NM_001767
  205468_s\_at                            0.015       IRF5          Interferon regulatory factor 5                                         1.52    NM_032643
  219386_s\_at                            \<0.001     SLAMF8        SLAM family member 8                                                   −2.27   NM_020125
  211192_s\_at                            \<0.001     CD84          CD84 molecule                                                          2.55    AF054818
  202269_x\_at                            0.006       GBP1          Guanylate-binding protein 1, interferon-inducible                      −1.77   NM_002053
  202621_at                               \<0.001     IRF3          Interferon regulatory factor 3                                         1.67    NM_001571
  33148_at                                \<0.001     ZFR           Zinc finger RNA binding protein                                        2.19    NM_016107
  206181_at                               0.003       SLAMF1        Signaling lymphocytic activation molecule family member 1              1.65    NM_003037
  215967_s\_at                            \<0.001     LY9           Lymphocyte antigen 9                                                   2.08    NM_002348
  201461_s\_at                            0.011       MAPKAPK2      Mitogen-activated protein kinase-activated protein kinase 2            1.85    NM_004759
  216450_x\_at                            \<0.001     HSP90B1       Heat shock protein 90 kDa beta (Grp94), member 1                       3.76    AK025862
  214370_at                               \<0.001     S100A8        S100 calcium-binding protein A8                                        3.65    AW238654
  *Antigen processing and presentation*                                                                                                            
  206050_s\_at                            0.010       RNH1          Ribonuclease/angiogenin inhibitor 1                                    −1.53   NM_002939
  204770_at                               \<0.001     TAP2          Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)            1.86    NM_000544
  *TH17 related genes*                                                                                                                             
  203233_at                               0.014       IL4R          Interleukin 4 receptor                                                 1.50    NM_000418
  204116_at                               \<0.001     IL2RG         Interleukin 2 receptor, gamma                                          1.84    NM_000206
  204863_s\_at                            \<0.001     IL6ST         Interleukin 6 signal transducer (gp130, oncostatin M receptor)         4.52    NM_002184
  205067_at                               0.015       IL1B          Interleukin 1, beta                                                    1.52    NM_000576
  205798_at                               0.011       IL7R          Interleukin 7 receptor                                                 1.55    NM_002185
  201332_s\_at                            0.013       STAT6         Signal transducer and activator of transcription 6                     1.54    AH006951
  205026_at                               \<0.001     STAT5B        Signal transducer and activator of transcription 5B                    1.60    NM_012448
  206360_s\_at                            \<0.001     SOCS3         Suppressor of cytokine signaling 3                                     1.83    NM_003955
  209774_x\_at                            0.015       CXCL2         Chemokine (C-X-C motif) ligand 2                                       1.53    M57731
  *Type I interferon signaling*                                                                                                                    
  211405_x\_at                            0.003       IFNA17        Interferon, alpha 17                                                   1.59    NM_021268
  205468_s\_at                            0.015       IRF5          Interferon regulatory factor 5                                         1.52    NM_032643
  202621_at                               \<0.001     IRF3          Interferon regulatory factor 3                                         1.67    NM_001571
  217199_s\_at                            \<0.001     STAT2         Signal transducer and activator of transcription 2, 113 kDa            1.59    S81491
  M97935_5\_at                            \<0.001     STAT1         Signal transducer and activator of transcription 1, 91 kDa             2.73    NM_007315
  210370_s\_at                            \<0.001     LY9           Lymphocyte antigen 9                                                   2.05    NM_002348

###### 

Biological processes and pathways enriched in the 15 modules.

  Biological processes                                                        *p* value   Pathways                                                                            *p* value
  --------------------------------------------------------------------------- ----------- ----------------------------------------------------------------------------------- -----------
  *M0*                                                                                                                                                                        
  Exocytosis                                                                  \<0.001     None                                                                                
  Secretion by cell                                                           \<0.001                                                                                         
  Secretion                                                                   \<0.001                                                                                         
  Vesicle-mediated transport                                                  0.0018                                                                                          
  Single-organism transport                                                   0.0220                                                                                          
  Single-organism localization                                                0.0308                                                                                          
  *M1*                                                                                                                                                                        
  T cell receptor signaling pathway                                           \<0.001     T cell activation                                                                   \<0.001
  Transmembrane receptor protein tyrosine kinase signaling pathway            \<0.001     B cell activation                                                                   0.0012
  T cell costimulation                                                        \<0.001     Cadherin signaling pathway                                                          0.0056
  Viral process                                                               \<0.001     Integrin signaling pathway                                                          0.0081
  Fc-gamma receptor signaling pathway involved in phagocytosis                \<0.001                                                                                         
  Peptidyl-tyrosine modification                                              0.0016                                                                                          
  Adaptive immune response                                                    0.0017                                                                                          
  Positive regulation of antigen receptor-mediated signaling pathway          0.0029                                                                                          
  Positive regulation of alpha-beta T cell proliferation                      0.0038                                                                                          
  Phosphatidylinositol phosphorylation                                        0.0060                                                                                          
  Phosphatidylinositol-mediated signaling                                     0.0162                                                                                          
  Positive regulation of calcium-mediated signaling                           0.0192                                                                                          
  T cell selection                                                            0.0244                                                                                          
  Leukocyte migration                                                         0.0303                                                                                          
  Interleukin-2-mediated signaling pathway                                    0.0324                                                                                          
  MAPK cascade                                                                0.0371                                                                                          
  Positive regulation of immune effector process                              0.0466                                                                                          
  Positive regulation of defense response                                     0.0485                                                                                          
  *M2*                                                                                                                                                                        
  mRNA export from nucleus                                                    \<0.001     None                                                                                
  Spliceosomal complex assembly                                               \<0.001                                                                                         
  Termination of RNA polymerase II transcription                              \<0.001                                                                                         
  Regulation of mRNA splicing, via spliceosome                                \<0.001                                                                                         
  Positive regulation of RNA splicing                                         \<0.001                                                                                         
  mRNA 3′-end processing                                                      \<0.001                                                                                         
  Regulation of gene silencing by miRNA                                       \<0.001                                                                                         
  tRNA export from nucleus                                                    0.0010                                                                                          
  Viral gene expression                                                       0.0054                                                                                          
  Intracellular transport of virus                                            0.0078                                                                                          
  Protein sumoylation                                                         0.0294                                                                                          
  Regulation of cellular response to heat                                     0.0310                                                                                          
  Fibroblast growth factor receptor signaling pathway                         0.0414                                                                                          
  *M3*                                                                                                                                                                        
  Positive regulation of T cell activation                                    0.0035      T cell activation                                                                   \<0.001
  Interleukin-2-mediated signaling pathway                                    0.0065      Interleukin signaling pathway                                                       \<0.001
  Interleukin-4-mediated signaling pathway                                    0.0065      PDGF signaling pathway                                                              0.0010
  Protein phosphorylation                                                     0.0349      Integrin signaling pathway                                                          0.0017
                                                                                          JAK/STAT signaling pathway                                                          0.0057
                                                                                          Hypoxia response via HIF activation                                                 0.0110
                                                                                          Insulin/IGF pathway-protein kinase B signaling cascade                              0.0136
                                                                                          p53 pathway feedback loops 2                                                        0.0176
                                                                                          PI3 kinase pathway                                                                  0.0182
                                                                                          VEGF signaling pathway                                                              0.0238
                                                                                          Endothelin signaling pathway                                                        0.0284
                                                                                          p53 pathway                                                                         0.0290
  *M4*                                                                                                                                                                        
  Pospholipase C-activating G-protein-coupled receptor signaling pathway      \<0.001     Heterotrimeric G-protein signal. pathway-Gq *α* and Go *α* med. pathway             \<0.001
  G-protein coupled acetylcholine receptor signaling pathway                  \<0.001                                                                                         
  Activation of phospholipase C activity                                      \<0.001     PI3 kinase pathway                                                                  \<0.001
  Positive regulation of cytosolic calcium ion concentration                  \<0.001     Endothelin signaling pathway                                                        0.0013
  Adenylate cyclase-modulating G-protein-coupled receptor signaling pathway   0.0048      Wnt signaling pathway                                                               0.0015
  *M5*                                                                                                                                                                        
  Translational initiation                                                    \<0.001     None                                                                                
  Nuclear-transcribed mRNA catabolic process, nonsense mediated decay         \<0.001                                                                                         
  SRP-dependent cotranslational protein targeting to membrane                 \<0.001                                                                                         
  rRNA processing                                                             \<0.001                                                                                         
  Ribosomal small subunit assembly                                            0.0083                                                                                          
  *M6*                                                                                                                                                                        
  Regulation of small GTPase-mediated signal transduction                     \<0.001     None                                                                                
  Positive regulation of GTPase activity                                      \<0.001                                                                                         
  Small GTPase-mediated signal transduction                                   \<0.001                                                                                         
  Actin cytoskeleton organization                                             0.0108                                                                                          
  *M7*                                                                                                                                                                        
  T cell costimulation                                                        \<0.001     T cell activation                                                                   \<0.001
  Phosphatidylinositol-mediated signaling                                     \<0.001     Integrin signaling pathway                                                          0.0041
  T cell receptor signaling pathway                                           \<0.001                                                                                         
  Phosphatidylinositol phosphorylation                                        \<0.001                                                                                         
  Transmembrane receptor protein tyrosine kinase signaling pathway            0.0016                                                                                          
  Peptidyl-tyrosine autophosphorylation                                       0.0033                                                                                          
  Viral process                                                               0.0035                                                                                          
  Fc receptor signaling pathway                                               0.0050                                                                                          
  Regulation of apoptotic process                                             0.0055                                                                                          
  Leukocyte differentiation                                                   0.0122                                                                                          
  Leukocyte migration                                                         0.0232                                                                                          
  Lymphocyte activation                                                       0.0237                                                                                          
  B cell receptor signaling pathway                                           0.0256                                                                                          
  Positive regulation of defense response                                     0.0340                                                                                          
  *M8*                                                                                                                                                                        
  Response to unfolded protein                                                \<0.001     None                                                                                
  Response to topologically incorrect protein                                 \<0.001                                                                                         
  Chaperone-mediated protein complex assembly                                 \<0.001                                                                                         
  Protein folding                                                             \<0.001                                                                                         
  Protein transmembrane transport                                             \<0.001                                                                                         
  Response to stress                                                          \<0.001                                                                                         
  *M9*                                                                                                                                                                        
  Activation of innate immune response                                        \<0.001     Toll-like receptor signaling pathway                                                \<0.001
  Positive regulation of innate immune response                               \<0.001     Ras pathway                                                                         \<0.001
  Toll-like receptor signaling pathway                                        \<0.001     Apoptosis signaling pathway                                                         \<0.001
  Fc-epsilon receptor signaling pathway                                       0.0020      T cell activation                                                                   \<0.001
  MAPK cascade                                                                0.0026      p38 MAPK pathway                                                                    \<0.001
  Positive regulation of type I interferon production                         0.0029      Oxidative stress response                                                           \<0.001
  Positive regulation of cytokine production                                  0.0035      Angiogenesis                                                                        \<0.001
  TRIF-dependent toll-like receptor signaling pathway                         0.0136      B cell activation                                                                   \<0.001
  Positive regulation of interferon-beta production                           0.0202      FGF signaling pathway                                                               \<0.001
  Response to lipopolysaccharide                                              0.0268      EGF receptor signaling pathway                                                      \<0.001
  Type I interferon biosynthetic process                                      0.0419      Integrin signaling pathway                                                          0.0024
                                                                                          Inflammation mediated by chemokine and cytokine signaling pathway                   0.0079
                                                                                                                                                                              
                                                                                          Interleukin signaling pathway                                                       0.0104
  *M10*                                                                                                                                                                       
  T cell receptor signaling pathway                                           \<0.001     T cell activation                                                                   \<0.001
  T cell costimulation                                                        \<0.001     EGF receptor signaling pathway                                                      \<0.001
  Fc-epsilon receptor signaling pathway                                       \<0.001     Integrin signaling pathway                                                          \<0.001
  phosphatidylinositol phosphorylation                                        \<0.001     p53 pathway feedback loops 2                                                        \<0.001
  Peptidyl-tyrosine autophosphorylation                                       \<0.001     VEGF signaling pathway                                                              \<0.001
  Fc-gamma receptor signaling pathway involved in phagocytosis                \<0.001     B cell activation                                                                   \<0.001
  Leukocyte migration                                                         \<0.001     Ras pathway                                                                         \<0.001
  Growth hormone receptor signaling pathway                                   \<0.001     Angiogenesis                                                                        \<0.001
  Regulation of defense response to virus                                     \<0.001     Insulin/IGF pathway-protein kinase B signaling cascade                              \<0.001
  Innate immune response                                                      \<0.001                                                                                         
  Positive regulation of MAP kinase activity                                  \<0.001     Inflammation mediated by chemokine and cytokine signaling pathway                   \<0.001
  T cell differentiation                                                      \<0.001                                                                                         
  Regulation of apoptotic process                                             \<0.001     PI3 kinase pathway                                                                  \<0.001
  JAK--STAT cascade                                                           0.0011      p53 pathway                                                                         \<0.001
  Positive regulation of immune effector process                              0.0031      Interferon-gamma signaling pathway                                                  \<0.001
  MAPK cascade                                                                0.0056      FGF signaling pathway                                                               \<0.001
  Adaptive immune response                                                    0.0088      Endothelin signaling pathway                                                        0.0101
  B cell receptor signaling pathway                                           0.0121      JAK/STAT signaling pathway                                                          0.0176
  Phosphatidylinositol 3-kinase signaling                                     0.0214                                                                                          
  Stimulatory C-type lectin receptor signaling pathway                        0.0363                                                                                          
  Innate immune response activ. cell surface receptor signal. pathway         0.0387                                                                                          
  *M11*                                                                                                                                                                       
  Cellular response to cytokine stimulus                                      \<0.001     JAK/STAT signaling pathway                                                          \<0.001
  JAK--STAT cascade involved in growth hormone signaling pathway              \<0.001     Interleukin signaling pathway                                                       \<0.001
  Positive regulation of cytokine production                                  \<0.001     PDGF signaling pathway                                                              \<0.001
  Response to interleukin-2                                                   \<0.001     Interferon-gamma signaling pathway                                                  \<0.001
  Positive regulation of T cell differentiation                               \<0.001     EGF receptor signaling pathway                                                      \<0.001
  Positive regulation of tyrosine phosphorylation of STAT protein             \<0.001     Integrin signaling pathway                                                          \<0.001
  Regulation of interferon-gamma-mediated signaling pathway                   \<0.001     Inflammation mediated by chemokine and cytokine signaling pathway                   \<0.001
  MAPK cascade                                                                \<0.001                                                                                         
  Adaptive immune response                                                    \<0.001     p53 pathway feedback loops 2                                                        0.0025
  Innate immune response                                                      0.0014      PI3 kinase pathway                                                                  0.0027
  Positive regulation of T cell proliferation                                 0.0022      VEGF signaling pathway                                                              0.0045
  Positive regulation of inflammatory response                                0.0025      B cell activation                                                                   0.0045
  Antigen receptor-mediated signaling pathway                                 0.0072      Ras pathway                                                                         0.0050
  T cell differentiation                                                      0.0085      T cell activation                                                                   0.0078
  Inflammatory response                                                       0.0194      Cadherin signaling pathway                                                          0.0201
  Positive regulation of antigen receptor-mediated signaling pathway          0.0227                                                                                          
  Transcription factor import into nucleus                                    0.0313                                                                                          
  T cell costimulation                                                        0.0396                                                                                          
  *M12*                                                                                   Inflammation mediated by chemokine and cytokine signaling pathway                   \<0.001
  G-protein-coupled receptor signaling pathway                                \<0.001                                                                                         
  Chemokine-mediated signaling pathway                                        \<0.001     Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha-mediated pathway   0.0473
  Positive regulation of cytosolic calcium ion concentration                  \<0.001                                                                                         
  Inflammatory response                                                       \<0.001                                                                                         
  Cell chemotaxis                                                             \<0.001                                                                                         
  Positive regulation of neutrophil chemotaxis                                0.0136                                                                                          
  Response to lipopolysaccharide                                              0.0268                                                                                          
  *M13*                                                                                                                                                                       
  Adherens junction assembly                                                  \<0.001     Integrin signaling pathway                                                          \<0.001
  Phosphatidylinositol phosphorylation                                        0.0015      Cadherin signaling pathway                                                          \<0.001
  Vesicle-mediated transport                                                  0.0026                                                                                          
  Positive regulation of protein localization to nucleus                      0.0043                                                                                          
  Actin cytoskeleton organization                                             0.0105                                                                                          
  Cell differentiation                                                        0.0308                                                                                          
  *M14*                                                                                                                                                                       
  Positive regulation of T cell activation                                    0.0035      T cell activation                                                                   \<0.001
  Interleukin-2-mediated signaling pathway                                    0.0065      Integrin signaling pathway                                                          \<0.001
  Interleukin-4-mediated signaling pathway                                    0.0065      Angiogenesis                                                                        0.0032
  Regulation of immune response                                               0.0430      Toll like receptor signaling pathway                                                0.0269
                                                                                          VEGF signaling pathway                                                              0.0387
                                                                                          B cell activation                                                                   0.0387
                                                                                          Ras pathway                                                                         0.0431

###### 

Selection of DEGs in NCGS that are also modulated in human T84 cells after stimulation with anti-VP7 rotavirus peptide antibodies.

  Gene symbol                           Accession number   Gene title                                                     FC NCGS PBCs   FC T84 treated cells
  ------------------------------------- ------------------ -------------------------------------------------------------- -------------- ----------------------
  *Apoptosis*                                                                                                                            
  SOCS3                                 NM_003955          Suppressor of cytokine signaling 3                             1.83           2.75
  ANXA6                                 NM_001155          Annexin A6                                                     1.57           2.72
  SOS2                                  NM_006939          Son of sevenless homolog 2 (Drosophila)                        1.90           1.75
  DEDD                                  AF064605           Death effector domain containing                               1.78           1.47
  *Immune response*                                                                                                                      
  IFNA17                                NM_021268          Interferon, alpha 17                                           1.59           1.56
  IL6R                                  S72848             Interleukin 6 receptor                                         1.79           2.76
  IRF5                                  NM_03264335        Interferon regulatory factor 5                                 1.52           1.52
  CD84                                  AF054818           CD84 molecule                                                  2.55           3.40
  *Inflammatory response*                                                                                                                
  IL1B                                  NM_000576          Interleukin 1, beta                                            1.52           1.80
  IL24                                  NM_006850          Interleukin 24                                                 2.84           2.19
  IL2RA                                 K03122             Interleukin 2 receptor, alpha                                  1.86           1.48
  S100A8                                AW238654           S100 calcium-binding protein A8                                3.65           1.86
  *Cell proliferation*                                                                                                                   
  FGFR2                                 NM_022975          Fibroblast growth factor receptor 2                            1.56           2.89
  RAC2                                  NM_002872          Ras-related C3 botulinum toxin substrate 2                     2.31           1.53
  CDK2                                  AB012305           Cyclin-dependent kinase 2                                      1.63           1.78
  DLG1                                  AL121981           Discs, large homolog 1 (Drosophila)                            1.57           1.74
  *Cell differentiation*                                                                                                                 
  GAS7                                  BC006454           Growth arrest-specific 7                                       −2.03          −1.90
  SRD5A1                                NM_001047          Steroid-5-alpha-reductase, alpha polypeptide 1                 −2.53          −1.54
  VAMP5                                 NM_006634          Vesicle-associated membrane protein 5                          −1.71          −1.58
  ZAK                                   NM_016653          Sterile alpha motif and leucine zipper containing kinase AZK   −2.02          −1.71
  *Cell--cell junctions*                                                                                                                 
  VCL                                   NM_014000          Vinculin                                                       −1.68          −1.56
  CTNND1                                NM_001331          Catenin (cadherin-associated protein), delta 1                 −2.33          −1.75
  CTNNA1                                NM_001903          Catenin (cadherin-associated protein), alpha 1, 102 kDa        −2.49          −1.57
  COL8A2                                NM_005202          Collagen, type VIII, alpha 2                                   −1.62          −1.64
  *Metalloproteases*                                                                                                                     
  ADAM8                                 AI814527           ADAM metallopeptidase domain 8                                 1.94           1.57
  ADAM9                                 NM_003816          ADAM metallopeptidase domain 9                                 2.81           1.48
  ADAM17                                AI797833           ADAM metallopeptidase domain 17                                1.51           1.56
  *Receptors and signal transduction*                                                                                                    
  IL2RA                                 K03122             Interleukin 2 receptor, alpha                                  1.86           1.48
  IRF5                                  NM_03264335        Interferon regulatory factor 5                                 1.52           1.52
  IL6R                                  S72848             Interleukin 6 receptor                                         1.79           2.76
  *Cytoskeleton*                                                                                                                         
  FGD6                                  NM_018351          FYVE, RhoGEF, and pH domain containing 6                       −2.40          −1.48
  ABLIM3                                NM_014945          Actin-binding LIM protein family, member 3                     1.86           1.49
  PFN2                                  NM_002628          Profilin 2                                                     1.51           1.47
  *Ion transport*                                                                                                                        
  SLC24A1                               AF026132           Solute carrier family 24 (Na/K/Ca exchanger), member 1         1.59           1.95
  SLC30A1                               AI972416           Solute carrier family 30 (zinc transporter), member 1          1.94           1.55
  SLC4A4                                AF069510           Solute carrier family 4, NaHCO~3~ cotransporter, member 4      1.52           1.92
  *EGFR signaling pathway*                                                                                                               
  AKT2                                  NM_001626          v-akt murine thymoma viral oncogene homolog 2                  2.36           2.19
  PIK3R1                                NM_181523          Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)        2.76           1.54
  PTPN12                                S69182             Protein tyrosine phosphatase, nonreceptor type 12              2.27           1.50

###### 

Genes modulated in the three datasets playing a role in selected GO BPs related to the viral infection process.

  Gene symbol                           Gene title                                                                   FC
  ------------------------------------- ---------------------------------------------------------------------------- ------
  *NCGS dataset*                                                                                                     
  Viral transcription/gene expression                                                                                
    RANBP2                              RAN-binding protein 2                                                        1.98
    RPL27A                              Ribosomal protein L27a                                                       3.22
    RPL37A                              Ribosomal protein L37a                                                       2.94
    RPLP2                               Ribosomal protein, large, P2                                                 2.15
    RPS10                               Ribosomal protein S10                                                        2.66
    RPS11                               Ribosomal protein S11                                                        2.49
    TPR                                 Translocated promoter region, nuclear basket protein                         4.40
  Response to virus                                                                                                  
    RELA                                v-rel reticuloendotheliosis viral oncogene homolog A (avian)                 1.54
    IKBKB                               Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta   2.69
    IRF5                                Interferon regulatory factor 5                                               1.52
    IFNA17                              Interferon, alpha 17                                                         1.59
    DDX3X                               DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked                           3.22
    STAT2                               Signal transducer and activator of transcription 2, 113 kDa                  1.59
    STAT1                               Signal transducer and activator of transcription 1, 91 kDa                   2.73
    IRF3                                Interferon regulatory factor 3                                               1.67
    DDX17                               DEAD (Asp-Glu-Ala-Asp) box helicase 17                                       4.75
  Viral life cycle                                                                                                   
    TPR                                 Translocated promoter region, nuclear basket protein                         4.40
    ATG16L1                             Autophagy-related 16-like 1 (*S. cerevisiae*)                                1.87
    HSP90AB1                            Heat shock protein 90 kDa alpha (cytosolic), class B member 1                1.87
    RANBP2                              RAN-binding protein 2                                                        1.98
    DPP4                                Dipeptidyl-peptidase 4                                                       1.61
    DDX6                                DEAD (Asp-Glu-Ala-Asp) box helicase 6                                        4.70
    HTATSF1                             HIV-1 Tat specific factor 1                                                  2.23
    SLAMF1                              Signaling lymphocytic activation molecule family member 1                    1.65
    T84 dataset                                                                                                      
  Viral transcription/gene expression                                                                                
    RPL27A                              Ribosomal protein L27a                                                       1.68
    RPS2                                Ribosomal protein S2                                                         1.99
    RPS6                                Ribosomal protein S6                                                         1.51
  Response to virus                                                                                                  
    IFIH1                               Interferon induced with helicase C domain 1                                  1.52
    IFNA7                               Interferon, alpha 7                                                          1.53
    IFIT3                               Interferon-induced protein with tetratricopeptide repeats 3                  1.46
    IFNA4                               Interferon, alpha 4                                                          1.73
    IFI44                               Interferon-induced protein 44                                                1.46
    IFNGR1                              Interferon gamma receptor 1                                                  1.67
    IFNA17                              Interferon, alpha 17                                                         1.56
  Viral life cycle                                                                                                   
    CTBP1                               C-terminal-binding protein 1                                                 1.58
    ADRBK1                              Adrenergic, beta, receptor kinase 1                                          1.46
    HCRP1                               Hepatocellular carcinoma-related HCRP1                                       1.61
    C9Orf28                             Chromosome 9 open reading frame 28                                           1.56
  Rotavirus infection dataset                                                                                        
  Viral transcription/gene expression                                                                                
    NUP58                               Nucleoporin 58 kDa                                                           6.38
    RPS16                               Ribosomal protein S16                                                        2.10
    DENR                                Density-regulated protein                                                    2.11
  Response to virus                                                                                                  
    XPR1                                Xenotropic and polytropic retrovirus receptor 1                              1.72
    CNOT7                               CCR4-NOT transcription complex subunit 7                                     3.54
    CD40                                CD40 molecule, TNF receptor superfamily member 5                             2.72
    ITCH                                Itchy E3 ubiquitin protein ligase                                            2.26
    ARF1                                ADP-ribosylation factor 1                                                    1.91
    BCL2L11                             BCL2-like 11 (apoptosis facilitator)                                         3.21
    BCL2L1                              BCL2-like 1                                                                  3.37
    IKBKE                               Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase ɛ      1.50
    DDX17                               DEAD (Asp-Glu-Ala-Asp) box helicase 17                                       2.13
  Viral life cycle                                                                                                   
    NUP153                              Nucleoporin 153 kDa                                                          2.01
    VPS37A                              Vacuolar protein sorting 37 homolog A (S. cerevisiae)                        1.90
    XPR1                                Xenotropic and polytropic retrovirus receptor 1                              1.72
    UBB                                 Ubiquitin B                                                                  1.75
    ITCH                                Itchy E3 ubiquitin protein ligase                                            2.26
    NUP58                               Nucleoporin 58 kDa                                                           6.38
    TNFRSF4                             Tumor necrosis factor receptor superfamily, member 4                         1.94
    SCARB2                              Scavenger receptor class B, member 2                                         1.96

###### 

Selection of genes modulated in human T84 cells after stimulation with anti-VP7 rotavirus peptide antibodies, involved in immune response and in molecular signaling related to the viral infection process.

  Gene symbol                                           Gene title                                                                              FC
  ----------------------------------------------------- --------------------------------------------------------------------------------------- -------
  *Immune response*                                                                                                                             
  CCR2                                                  Chemokine (C-C motif) receptor 2                                                        −1.48
  CXCL1                                                 Chemokine (C-X-C motif) ligand 1                                                        1.81
  CXCL13                                                Chemokine (C-X-C motif) ligand 13                                                       −5.52
  GATA3                                                 GATA-binding protein 3                                                                  −6.62
  TROVE2                                                TROVE domain family, member 2                                                           −1.64
  ICOSLG                                                Inducible T cell costimulator ligand                                                    2.51
  FCGR1A                                                Fc fragment of IgG, high affinity Ia, receptor (CD64)                                   2.00
  FOXP3                                                 Forkhead box P3                                                                         1.49
  ULBP1                                                 UL16-binding protein 1                                                                  −1.77
  ITGA4                                                 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)                    1.48
  CXCL9                                                 Chemokine (C-X-C motif) ligand 9                                                        1.59
  CSF3                                                  Colony-stimulating factor 3 (granulocyte)                                               1.46
  IL6                                                   Interleukin 6 (interferon, beta 2)                                                      1.51
  CD84                                                  CD84 molecule                                                                           3.40
  FCGR2B                                                Fc fragment of IgG, low affinity IIb, receptor (CD32)                                   1.77
  LAT2                                                  Linker for activation of T cells family, member 2                                       1.85
  C7                                                    Complement component 7                                                                  3.11
  CCR1                                                  Chemokine (C-C motif) receptor 1                                                        3.27
  CCR3                                                  Chemokine (C-C motif) receptor 3                                                        2.80
  CFP                                                   Complement factor properdin                                                             2.92
  IL24                                                  Interleukin 24                                                                          2.19
  IL8                                                   Interleukin 8                                                                           1.86
  CXCL10                                                Chemokine (C-X-C motif) ligand 10                                                       1.82
  IL1F7                                                 Interleukin 1 family, member 7 (zeta)                                                   −2.26
  IKBKB                                                 Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta              −2.25
  CCL11                                                 Chemokine (C-C motif) ligand 11                                                         1.96
  *Type I interferon signaling*                                                                                                                 
  Cellular response to interferon alpha                                                                                                         
   FCAR                                                 Fc fragment of IgA, receptor for                                                        2.15
  Type I interferon signaling                                                                                                                   
   IFNA16                                               Interferon, alpha 16                                                                    1.58
   STAT1                                                Signal transducer and activator of transcription 1, 91 kDa                              −1.46
   IFNA17                                               Interferon, alpha 17                                                                    1.56
   YY1                                                  YY1 transcription factor                                                                −2.24
   IFNA4                                                Interferon, alpha 4                                                                     1.73
   IRF8                                                 Interferon regulatory factor 8 interferon regulatory factor 8                           −1.68
   IFNA5                                                Interferon, alpha 5                                                                     −2.85
   IRF2                                                 Interferon regulatory factor 2                                                          1.58
   IFNA8                                                Interferon, alpha 8                                                                     2.23
   IRF5                                                 Interferon regulatory factor 5                                                          1.52
   IFI6                                                 Interferon, alpha-inducible protein 6                                                   1.56
   IFNA6                                                Interferon, alpha 6                                                                     2.08
  Positive regulation of interferon alpha production                                                                                            
   IRF5                                                 Interferon regulatory factor 5                                                          1.52
  Positive regulation of interferon beta production                                                                                             
   DDX3X                                                DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked                                      −1.49
   IRF5                                                 Interferon regulatory factor 5                                                          1.52
  Negative regulation of interferon beta production                                                                                             
   LILRB1                                               Leukocyte immunoglobulin-like receptor, subfamily B, member 1                           −1.60
  Positive regulation of Type I interferon production                                                                                           
   IFI16                                                Interferon, gamma-inducible protein 16                                                  −1.68
   CREBBP                                               CREB-binding protein (Rubinstein-Taybi syndrome)                                        1.51
  Negative regulation of Type I interferon production                                                                                           
   CYLD                                                 Cylindromatosis (turban tumor syndrome)                                                 −3.04
  *Gamma interferon signaling*                                                                                                                  
  Cellular response to Interferon Gamma signaling                                                                                               
   FCAR                                                 Fc fragment of IgA, receptor for                                                        2.15
   MRC1                                                 Mannose receptor, C type 1                                                              2.52
   SYNCRIP                                              Synaptotagmin-binding, cytoplasmic RNA-interacting protein                              −1.69
   CCL8                                                 chemokine (C-C motif) ligand 8                                                          1.63
  Interferon gamma signaling                                                                                                                    
   STAT1                                                Signal transducer and activator of transcription 1, 91 kDa                              −1.46
   MID1                                                 Midline 1 (Opitz/BBB syndrome)                                                          −1.99
   HLA-DRB4                                             Major histocompatibility complex, class II, DR beta 4                                   2.39
   SDK1                                                 Sidekick homolog 1 (chicken)                                                            1.61
   IFNGR1                                               Interferon gamma receptor 1 interferon gamma receptor 1                                 1.67
  Negative regulation of gamma interferon production                                                                                            
   LILRB1                                               Leukocyte immunoglobulin-like receptor, subfamily B, member 1                           −1.60
   CD244                                                CD244 molecule, natural killer cell receptor 2B4                                        −1.69
   IL10                                                 Interleukin 10                                                                          −3.56
  Positive regulation of gamma interferon production                                                                                            
   FOXP3                                                Forkhead box P3                                                                         1.49
   IL1B                                                 Interleukin 1, beta                                                                     1.80
  *Toll-like receptor signaling*                                                                                                                
  TANK                                                  TRAF family member-associated NFKB activator                                            −1.91
  CHUK                                                  Conserved helix-loop-helix ubiquitous kinase                                            −1.72
  ELK1                                                  ELK1, member of ETS oncogene family                                                     3.70
  MAP3K8                                                Mitogen-activated protein kinase kinase kinase 8                                        −2.16
  TLR6                                                  Toll-like receptor 6                                                                    2.43
  TLR1                                                  Toll-like receptor 1                                                                    1.57
  TLR7                                                  Toll-like receptor 7                                                                    −1.64
  MAP3K7                                                Mitogen-activated protein kinase kinase kinase 7                                        −1.89
  LY96                                                  Lymphocyte antigen 96                                                                   −1.81
  NFKB2                                                 Nuclear factor of kappa light polypeptide gene enhancer in B cells 2 (p49/p100)         1.54
  REL                                                   v-rel reticuloendotheliosis viral oncogene homolog (avian)                              −1.82
  PTGS2                                                 Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)   1.76
  TNFAIP3                                               Tumor necrosis factor, alpha-induced protein 3                                          1.73
  MAP2K3                                                Mitogen-activated protein kinase kinase 3                                               1.59
  IKBKB                                                 Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta              −2.25
  TLR3                                                  Toll-like receptor 3                                                                    −2.03
  IFNB1                                                 Interferon, beta 1, fibroblast                                                          −1.84
  IRAK3                                                 Interleukin-1 receptor-associated kinase 3                                              1.70
  TLR4                                                  Toll-like receptor 4                                                                    1.46
  IKBKE                                                 Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase epsilon           2.06
  MAP2K2                                                Mitogen-activated protein kinase kinase 2                                               1.98
  TLR2                                                  Toll-like receptor 2                                                                    −2.30

###### 

Selection of genes modulated in PBCs in course of the acute phase of rotavirus infection, involved in immune response and in molecular signaling related to the viral infection process.

  Gene symbol                                           Gene title                                                                                     FC
  ----------------------------------------------------- ---------------------------------------------------------------------------------------------- --------
  *Immune response*                                                                                                                                    
  ADGRE3                                                Adhesion G protein-coupled receptor E3;ADGRE3;ortholog                                         −3.35
  ADIPOQ                                                Adiponectin, C1Q and collagen domain containing                                                −1.60
  BLK                                                   BLK proto-oncogene, Src family tyrosine kinase                                                 1.72
  BRAF                                                  B-Raf proto-oncogene, serine/threonine kinase                                                  1.57
  BTK                                                   Bruton agammaglobulinemia tyrosine kinase                                                      −1.59
  C1QTNF9                                               C1q and tumor necrosis factor related protein 9                                                −1.69
  CD109                                                 CD109 molecule                                                                                 −1.84
  CD79B                                                 CD79b molecule, immunoglobulin-associated beta                                                 −1.67
  CLEC7A                                                C-type lectin domain family 7, member A                                                        −1.62
  CMIP                                                  c-Maf inducing protein                                                                         −3.50
  CSF2RA                                                Colony-stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)             −2.30
  CXCL2                                                 Chemokine (C-X-C motif) ligand 2                                                               −3.76
  CXCL8                                                 Chemokine (C-X-C motif) ligand 8                                                               −8.65
  FCER1A                                                Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide                           −5.64
  HCST                                                  Hematopoietic cell signal transducer                                                           1.85
  IL18BP                                                Interleukin 18 binding protein                                                                 1.56
  JAG1                                                  Jagged 1                                                                                       −2.06
  KLRB1                                                 Killer cell lectin-like receptor subfamily B, member 1                                         −5.99
  MAP3K11                                               Mitogen-activated protein kinase kinase kinase 11                                              1.55
  MASP1                                                 Mannan-binding lectin serine peptidase 1                                                       −1.50
  MR1                                                   Major histocompatibility complex, class I-related                                              8.43
  PLEKHN1                                               Pleckstrin homology domain containing, family N member 1                                       −1.99
  PPP2R2C                                               Protein phosphatase 2, regulatory subunit B, gamma                                             −1.84
  PPP3CA                                                Protein phosphatase 3, catalytic subunit, alpha isozyme                                        −1.89
  PSME3                                                 Proteasome activator subunit 3                                                                 1.91
  PVR                                                   Poliovirus receptor                                                                            −1.59
  STAT5B                                                Signal transducer and activator of transcription 5B                                            −2.06
  TNFRSF10C                                             Tumor necrosis factor receptor superfamily, member 10c decoy without an intracellular domain   −1.75
  TNFRSF4                                               Tumor necrosis factor receptor superfamily, member 4                                           1.94
  *Type I interferon signaling*                                                                                                                        
  Positive regulation of Type I interferon production                                                                                                  
   EP300                                                E1A-binding protein p300                                                                       −1.56
   POLR3G                                               Polymerase (RNA) III (DNA directed) polypeptide G (32kD)                                       −1.98
   CREBBP                                               CREB-binding protein                                                                           −1.83
   LRRFIP1                                              Leucine rich repeat (in FLII) interacting protein 1                                            −2.14
   SOCS1                                                Suppressor of cytokine signaling 1                                                             2.32
  Negative regulation of Type I interferon production                                                                                                  
   UBB                                                  Ubiquitin B                                                                                    1.75
   ITCH                                                 Itchy E3 ubiquitin protein ligase                                                              2.26
   TAX1BP1                                              Tax1 (human T cell leukemia virus type I) binding protein 1                                    −4.01
  Negative regulation of Type I interferon pathway                                                                                                     
   PTPN2                                                Protein tyrosine phosphatase, nonreceptor type 2                                               2.10
  Positive regulation of interferon beta production                                                                                                    
   ZBTB20                                               Zinc finger and BTB domain containing 20                                                       4.27
  Negative regulation of interferon Beta production                                                                                                    
   PTPRS                                                Protein tyrosine phosphatase, receptor type, S                                                 −2.00
   CACTIN                                               Cactin, spliceosome C complex subunit                                                          −2.53
  Cellular response to interferon alpha                                                                                                                
   TPR                                                  Translocated promoter region, nuclear basket protein                                           −2.55
  Negative regulation of interferon alpha production                                                                                                   
   PTPRS                                                Protein tyrosine phosphatase, receptor type, S                                                 −2.00
  Type I interferon signaling pathway                                                                                                                  
   JAK1                                                 Janus kinase 1                                                                                 1.79
   IFI27                                                Interferon, alpha-inducible protein 27                                                         75.26
   IFI27L2                                              Interferon, alpha-inducible protein 27-like 2                                                  −1.59
   IKBKE                                                Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase epsilon                  1.50
   TPR                                                  Translocated promoter region, nuclear basket protein                                           −2.55
  Positive regulation of Type I interferon pathway                                                                                                     
   MME                                                  Membrane metallo-endopeptidase                                                                 −5.54
  *Gamma interferon signaling*                                                                                                                         
  JAK1                                                  Janus kinase 1                                                                                 1.79
  HLADQB1                                               Major histocompatibility complex, class II, DQ beta 1                                          −36.43
  HLADQA1                                               Major histocompatibility complex, class II, DQ alpha 1                                         −37.95
  PIAS3                                                 Protein inhibitor of activated STAT 3                                                          2.11
  HLADRB1                                               Major histocompatibility complex, class II, DR beta 1                                          −10.91
  MAPK8                                                 Mitogen-activated protein kinase 8                                                             −2.28
  MAPK1                                                 Mitogen-activated protein kinase 1                                                             −2.23
  Regulation of interferon gamma signaling pathway                                                                                                     
   PTPN2                                                Protein tyrosine phosphatase, nonreceptor type 2                                               2.10
  Positive regulation of interferon gamma production                                                                                                   
   PDE4B                                                Phosphodiesterase 4B, cAMP-specific                                                            −1.77
   ZFPM1                                                Zinc finger protein, FOG family member 1                                                       1.75
  Negative regulation of interferon gamma production                                                                                                   
   HLADRB1                                              Major histocompatibility complex, class II, DR beta 1                                          −10.91
   RARA                                                 Retinoic acid receptor, alpha                                                                  −7.60
   FOXP3                                                Forkhead box P3                                                                                −2.14
  Cellular response to interferon gamma                                                                                                                
   SLC26A6                                              Solute carrier family 26 (anion exchanger), member 6                                           1.95
   DAPK3                                                Death-associated protein kinase 3                                                              −1.62
   CD40                                                 CD40 molecule, TNF receptor superfamily member 5                                               2.72
   MEFV                                                 Mediterranean fever                                                                            −4.83
   SNCA                                                 Synuclein alpha                                                                                8.62
   MRC1                                                 Mannose receptor, C type 1                                                                     −1.93
  *Toll-like receptors signaling pathway*                                                                                                              
  TANK                                                  TRAF family member-associated NFKB activator                                                   −1.91
  NFKBIA                                                Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha            −1.76
  MAPK8                                                 Mitogen-activated protein kinase 8                                                             −2.28
  IKBKE                                                 Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase epsilon                  1.50
  MAPK1                                                 Mitogen-activated protein kinase 1                                                             −2.23
  JUN                                                   jun proto-oncogene                                                                             −1.91
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